Vyne Therapeutics Inc. (VYNE)
NASDAQ · Healthcare
Vyne Therapeutics Inc. Net Income 2016–2025
Vyne Therapeutics Inc. annual/quarterly net income history and growth rate from 2016 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Vyne Therapeutics Inc. net income for the quarter ending March 31, 2026 was -3.6 M, a 58.37% decrease year-over-year.
- Vyne Therapeutics Inc. net income for the twelve months ending March 31, 2026 was -30.1 M, a 6.78% decrease year-over-year.
- Vyne Therapeutics Inc. annual net income for 2025 was -26.5 M, a 33.52% decrease from 2024.
- Vyne Therapeutics Inc. annual net income for 2024 was -39.8 M, a 40.00% increase from 2023.
- Vyne Therapeutics Inc. annual net income for 2023 was -28.5 M, a 22.59% increase from 2022.
- Vyne Therapeutics Inc. annual net income for 2022 was -23.2 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Vyne Therapeutics Inc. Net Income — FAQ
Vyne Therapeutics Inc. (VYNE) net income over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
What is Vyne Therapeutics Inc.'s net income?
Vyne Therapeutics Inc. (VYNE) reported net income of -$26M for fiscal 2025.
Where can I see VYNE's net income history?
The chart and table above show Vyne Therapeutics Inc.'s net income by year and by quarter, including the growth rate.